Literature DB >> 23902651

Improvement of cerebral oxygen saturation after successful electrical cardioversion of atrial fibrillation.

Alexander Wutzler1, Jens Nee, Leif-Hendrik Boldt, York Kühnle, Saskia Gräser, Tim Schröder, Wilhelm Haverkamp, Christian Storm.   

Abstract

AIMS: Cerebral and microvascular perfusion is reduced in atrial fibrillation (AF). Maintenance of brain perfusion is important in acute disease and long-term course. Assessment of brain perfusion and oxygenation is difficult in clinical practice. Our study aimed to determine changes in cerebral tissue oxygen saturation (SctO2) with bedside near-infrared spectroscopy (NIRS). METHODS AND
RESULTS: Twenty patients (mean age 67.7 ± 10.2 years, 50% men) in whom electrical cardioversion (CV) was successful were prospectively studied. Ten patients (mean age 64.2 ± 7.7 years, 80% men) in whom CV was not successful served as control group. Bilateral SctO2, mean arterial pressure (MAP), arterial oxygen saturation (SaO2), and heart rate were recorded and changes of all parameters before and after CV were compared between the groups. Our results show an increase in SctO2 after successful CV that was significantly higher compared with patients who remained in AF (right SctO2 3.25 ± 2.5 vs. -0.13 ± 0.52%, P = 0.001; left SctO2 4.27 ± 3.56 vs. -0.38 ± 2.4%, P < 0.001). Neither arterial blood pressure nor SaO2 changes differed significantly between the two groups. No correlation could be detected between the significant increase of SctO2 after successful CV and arterial blood pressure, SaO2, or heart rate.
CONCLUSION: Cerebral tissue oxygen saturation increases significantly after restoration of sinus rhythm. Near-infrared spectroscopy monitoring can identify changes of SctO2 after successful CV of AF independent from standard monitoring parameters (MAP, SaO2). Near-infrared spectroscopy can be used to detect cerebral oxygen saturation deficits in AF patients or patients at high risk for AF. Clinical applications may include monitoring during ablation procedures and in critical care.

Entities:  

Keywords:  Atrial fibrillation; Cardioversion; Cerebral oxygen saturation; Monitoring; Near-infrared spectroscopy

Mesh:

Substances:

Year:  2013        PMID: 23902651     DOI: 10.1093/europace/eut246

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

Review 1.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

Review 2.  Cerebral near-infrared spectroscopy in the care of patients during cardiological procedures: a summary of the clinical evidence.

Authors:  Annelies Moerman; Frederik Meert; Stefan De Hert
Journal:  J Clin Monit Comput       Date:  2015-10-08       Impact factor: 2.502

3.  Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion.

Authors:  Marianna Gardarsdottir; Sigurdur Sigurdsson; Thor Aspelund; Hrafnhildur Rokita; Lenore J Launer; Vilmundur Gudnason; David O Arnar
Journal:  Europace       Date:  2018-08-01       Impact factor: 5.214

4.  Improved brain perfusion after electrical cardioversion of atrial fibrillation.

Authors:  Marianna Gardarsdottir; Sigurdur Sigurdsson; Thor Aspelund; Valdis Anna Gardarsdottir; Lars Forsberg; Vilmundur Gudnason; David O Arnar
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

5.  Cerebral and Limb Tissue Oxygenation During Peripheral Venoarterial Extracorporeal Life Support.

Authors:  Nousjka P A Vranken; Anouk A M A Lindelauf; Antoine P Simons; Marcel J H Ariës; Jos G Maessen; Patrick W Weerwind
Journal:  J Intensive Care Med       Date:  2017-10-15       Impact factor: 3.510

6.  The Impact of Personal Thoracic Impedance on Electrical Cardioversion in Patients with Atrial Arrhythmias.

Authors:  Seung-Young Roh; Jinhee Ahn; Kwang-No Lee; Yong-Soo Baek; Dong-Hyeok Kim; Dae-In Lee; Jaemin Shim; Jong-Il Choi; Young-Hoon Kim
Journal:  Medicina (Kaunas)       Date:  2021-06-13       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.